The table below shows DEXCOM INC's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
$1.44B
$989.50M
$748.50M
$669.50M
$442.50M
$475.60M
Capital expenditure
$363.50M
$358.80M
$236.60M
$364.80M
$389.20M
$199.00M
Investing cash flow
$536.00M
-$207.50M
-$507.20M
-$521.50M
-$216.10M
-$1.02B
Dividends paid
-
-
-
-
-
DXCM operating cash flow (10-K history)
DEXCOM INC reported operating cash flow of $1.44B for fiscal year 2025. That is up 45.6% from $989.50M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $56.20M (FY 2016) to $1.44B. Figures come from the company's audited annual reports as filed with the SEC.
